Targeting Redox Signaling Through Exosomal MicroRNA: Insights into Tumor Microenvironment and Precision Oncology
Antioxidants · 22.04.2025 · 14 (5) · 501
DOI: 10.3390/antiox14050501 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 22.04.2025. Verfasst von Moon Nyeo Park und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Korean Medicine, Kyung Hee University, 1-5 Hoegidong, Dongdaemun-gu, Seoul 02447, Republic of Korea. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Health & Welfare, Republic of Korea, Starting Growth Technological R&D Program.
Abstract (Originalsprache)
Reactive oxygen species (ROS) play a dual role in cancer progression, acting as both signaling molecules and drivers of oxidative damage. Emerging evidence highlights the intricate interplay between ROS, microRNAs (miRNAs), and exosomes within the tumor microenvironment (TME), forming a regulatory axis that modulates immune responses, angiogenesis, and therapeutic resistance. In particular, oxidative stress not only stimulates exosome biogenesis but also influences the selective packaging of redox-sensitive miRNAs (miR-21, miR-155, and miR-210) via RNA-binding proteins such as hnRNPA2B1 and SYNCRIP. These miRNAs, delivered through exosomes, alter gene expression in recipient cells and promote tumor-supportive phenotypes such as M2 macrophage polarization, CD8+ T-cell suppression, and endothelial remodeling. This review systematically explores how this ROS–miRNA–exosome axis orchestrates communication across immune and stromal cell populations under hypoxic and inflammatory conditions. Particular emphasis is placed on the role of NADPH oxidases, hypoxia-inducible factors, and autophagy-related mechanisms in regulating exosomal output. In addition, we analyze the therapeutic relevance of natural products and herbal compounds—such as curcumin, resveratrol, and ginsenosides—which have demonstrated promising capabilities to modulate ROS levels, miRNA expression, and exosome dynamics. We further discuss the clinical potential of leveraging this axis for cancer therapy, including strategies involving mesenchymal stem cell-derived exosomes, ferroptosis regulation, and miRNA-based immune modulation. Incorporating insights from spatial transcriptomics and single-cell analysis, this review provides a mechanistic foundation for the development of exosome-centered, redox-modulating therapeutics. Ultimately, this work aims to guide future research and drug discovery efforts toward integrating herbal medicine and redox biology in the fight against cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Korean Medicine, Kyung Hee University, 1-5 Hoegidong, Dongdaemun-gu, Seoul 02447, Republic of Korea.
- Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Sam Ratulangi, Manado 95115, Indonesia.
- Department of Biology, Faculty of Medicine, Universitas Sam Ratulangi, Manado 95115, Indonesia.
- Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Hoegi-dong, Dongdaemun-gu, Seoul 02447, Republic of Korea.
ORCID-Profile: Moon Nyeo Park, Trina Ekawati Tallei, Woojin Kim, Bonglee Kim
Förderung
- National Research Foundation of Korea
- Ministry of Health & Welfare, Republic of Korea
- Starting Growth Technological R&D Program
- Ministry of Education
- Korean government (MSIT)
- Ministry of Health & Welfare, Republic of Korea
- Ministry of SMEs and Startups (MSS, Korea)
Zitieren
APA
Park, M. N., Kim, M., Lee, S., Kang, S., Ahn, C. H., Tallei, T. E., Kim, W., & Kim, B. (2025). Targeting Redox Signaling Through Exosomal MicroRNA: Insights into Tumor Microenvironment and Precision Oncology. Antioxidants, 14(5), 501. https://doi.org/10.3390/antiox14050501
Vancouver
Park MN, Kim M, Lee S, Kang S, Ahn CH, Tallei TE, et al. Targeting Redox Signaling Through Exosomal MicroRNA: Insights into Tumor Microenvironment and Precision Oncology. Antioxidants. 2025;14(5):501. doi:10.3390/antiox14050501
BibTeX
@article{Park2025,
author = {Park, Moon Nyeo and Kim, Myoungchan and Lee, Soojin and Kang, Sojin and Ahn, Chi-Hoon and Tallei, Trina Ekawati and Kim, Woojin and Kim, Bonglee},
title = {Targeting Redox Signaling Through Exosomal MicroRNA: Insights into Tumor Microenvironment and Precision Oncology},
journal = {Antioxidants},
year = {2025},
volume = {14},
number = {5},
pages = {501},
doi = {10.3390/antiox14050501}
}
EUVIMED